3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
24
Neoplasm Metastasis
3
Ovarian Neoplasms
2
Prostatic Neoplasms
1
Premenopausal Breast Cancer
1
Pancreatic Neoplasms
1
Invasive Early Breast Cancer
1
First Line Metastatic Breast Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms, Male
1
Breast Cancer Metastatic
1
Interventions
Fulvestrant
2
tusamitamab ravtansine
1
palbociclib
1
nirogacestat
1
exemestane
1
Tamoxifen
1
Letrozole
1
Gemcitabine
1
Docetaxel
1
Capecitabine
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Breast Cancer Metastatic
×
exemestane
×
Clear all
NCT04059484
2026-02-24
AMEERA-3
Sanofi
Phase 2
Terminated
367 enrolled
30 charts